Covert hepatic encephalopathy and spontaneous portosystemic shunts increase the risk of developing overt hepatic encephalopathy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Covert hepatic encephalopathy and spontaneous portosystemic shunts increase the risk of developing overt hepatic encephalopathy

Published:2020-11-30 Issue:12 Volume:40 Page:3093-3102
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Greinert Robin¹^ORCID,Zipprich Alexander¹,Simón‐Talero Macarena²,Stangl Franz³,Ludwig Christiane¹,Wienke Andreas⁴,Praktiknjo Michael⁵^ORCID,Höhne Kevin¹,Trebicka Jonel⁶^ORCID,Genescà Joan²,Ripoll Cristina¹

Affiliation:

1. First Department of Internal Medicine Martin‐Luther University Halle‐Wittenberg Halle Germany

2. Liver Unit Department of Internal Medicine Hospital Universitari Vall d’HebronVall d’Hebron Institut de Recerca (VHIR)CIBEREHDUniversitat Autònoma de Barcelona Barcelona Spain

3. Department of Radiology Martin‐Luther University Halle‐Wittenberg Halle Germany

4. Institute of Medical Epidemiology, Biostatistics, and Informatics Martin‐Luther‐University Halle‐Wittenberg Halle Germany

5. Medizinische Klinik IUniversitätsklinikum Bonn Bonn Germany

6. Medizinische Klinik 1 Universitätsklinikum Frankfurt. Goethe Universität Frankfurt Germany

Funder

Instituto de Salud Carlos III

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/liv.14660

Reference31 articles.

1. Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases;American Association for the Study of Liver Diseases; European Association for the Study of the Liver;J Hepatol,2014

2. Stepwise diagnosis in covert hepatic encephalopathy: critical flicker frequency and MELD-score as a first-step approach

3. Value of the critical flicker frequency in patients with minimal hepatic encephalopathy

4. Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study

5. Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prophylaxis of hepatic encephalopathy: current and future drug targets;Hepatology International;2024-03-16

2. Concurrent spontaneous portosystemic shunt embolization for the prevention of overt hepatic encephalopathy after TIPS: A systematic review and meta-analysis;Digestive and Liver Disease;2023-11

3. Deranged Biochemical Markers As Early Predictors for the Development of Hepatorenal Syndrome in Patients With Alcoholic Liver Cirrhosis;Cureus;2023-10-29

4. Prediction and prevention of the first episode of overt hepatic encephalopathy in patients with cirrhosis;Hepatology Communications;2023-03-17

5. Large Paraumbilical Vein Shunts Increase the Risk of Overt Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt Placement;Journal of Clinical Medicine;2022-12-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3